Gilead sec 10k
WebSEC Filing Details SEC Filing Details ... Form. 10-K Filing Date. Feb 27, 2024. Document Date. Dec 31, 2024. Form Description. Annual report which provides a comprehensive overview of the company for the past year. Filing Group. Annual Filings. Company. Gilead Sciences. Issuer. GILEAD SCIENCES, INC. Filing Formats. View HTML. Download PDF ... WebFeb 1, 2024 · As of December 31, 2024, Gilead had $7.8 billion of cash, cash equivalents and marketable debt securities compared to $7.9 billion as of December 31, 2024. During the fourth quarter 2024, Gilead generated $3.2 billion in operating cash flow. During the fourth quarter 2024, Gilead repaid $1.0 billion in debt, paid cash dividends of $894 million ...
Gilead sec 10k
Did you know?
WebThis website may contain information considered to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that reflects management's expectations. ... These and other risks are described in detail in Gilead’s most recently filed Annual Reports on Form 10-K and in Gilead’s Quarterly Reports ... WebAt Gilead, we promise to treat your data with respect. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you …
WebGilead Sciences Inc SEC 10-K filing for December 31, 2024. Review the company's business, risk factors, legal proceedings and financial data. ... the following filings as soon as reasonably practicable after they are electronically filed with or furnished to the SEC: our Annual Reports on Form 10-K; Quarterly Reports on Form 10-Q; Current ... WebAn annual report to security holders. View HTML. 0001193125-23-072650.pdf. Mar 15, 2024: DEFA14A: Additional proxy soliciting materials - definitive ... You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc ...
WebForm 10-K. 4Q22 Other Financial Disclosures (Excel) 4Q22 Prepared Remarks. ... SEC filings. See filings. View or download our latest filings with the United States Securities and Exchange Commission. Sign up for email alerts. Receive company news, … WebApr 28, 2024 · Gilead directs readers to its press releases, annual reports on Form 10-K, quarterly reports on Form 10-Q and other subsequent disclosure documents filed with the SEC. Gilead claims the protection of the Safe Harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements.
WebJul 29, 2024 · As of June 30, 2024, Gilead had $7.4 billion of cash, cash equivalents and marketable debt securities compared to $7.9 billion as of December 31, 2024. During the second quarter 2024, Gilead generated $2.3 billion in operating cash flow. During the second quarter 2024, Gilead paid cash dividends of $894 million and utilized $43 million …
WebANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000 … schedule e from tax returnWebMar 23, 2024 · Gilead Sciences, Inc. (GILD) SEC Filing DEF 14A Proxy Statement Report. Home. SEC Filings. Gilead Sciences Inc (GILD) DEF 14A Proxy Statement Report Thu Mar 23 2024; SEC Filings. ... Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats. Last10K.com Member Feature. Export Annual and Quarterly Reports … schedule eic form 2017WebApr 28, 2024 · Gilead directs readers to its press releases, annual reports on Form 10-K, quarterly reports on Form 10-Q and other subsequent disclosure documents filed with … schedule e hoa feesWebJul 21, 2024 · Foster City, Calif. and South San Francisco, Calif., July 21, 2024 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that it will invest $300 million to acquire a 49.9 percent equity interest in Tizona Therapeutics Inc., a privately held company developing first-in-class cancer immunotherapies. Gilead will also receive an exclusive ... schedule eic 2020 worksheet aWebMay 4, 2024 · united states securities and exchange commission washington, d.c. 20549 form 10-k (mark one) ☒ annual report pursuant to section 13 or 15(d) of the securities … schedule e how toWebMar 3, 2024 · SEC Filings. allform. allform. Form Description Filed Date Downloads; 8-K: Current report filing: March 29, 2024: Download Download Download Download Download: 4: Statement of Changes in Beneficial Ownership ... 10-K: Annual Report: February 27, 2024: Download Download Download Download Download Download: 8-K: Current … russians immigrating to usaWebAlthough Gilead supports all SDGs, we have identified key goals where we can deliver our greatest influence and positive impact. In particular, Gilead’s mission to provide lifesaving therapeutics to marginalized and underserved communities aligns strongly with SDG 3, “Good Health and Well-Being.” As Gilead expands our schedule eic form 2021